Commit To Purchase RAPT Therapeutics At $2.50, Earn 13.4% Annualized Using Options
May 16, 2024 at 11:35 AM EDT
Investors considering a purchase of RAPT Therapeutics Inc (RAPT) stock, but cautious about paying the going market price of $4.22/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the December put at the $2.50 strike, which has a bid at the time of this writing of 20 cents..